A real-world study finds favorable stone-free rates after use of SURE with the CVAC® system to treat kidney stone burdens typically less than 2 cm. Despite its relatively novel status, steerable ...
Calyxo Closes on $50 Million Equity Financing to Support Broad Launch of CVAC Kidney Stone Treatment
PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing next-generation treatment solutions for patients with kidney stones, has announced the closing of a $50 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback